Revised SPC: Ferinject (ferric carboxymaltose)

SPC now warns that symptomatic hypophosphataemia leading to osteomalacia and fractures requiring clinical intervention including surgery has been reported in the post marketing setting. Patients advised to report worsening fatigue with myalgias or bone pain.

Source:

electronic Medicines compendium